MassMutual Private Wealth & Trust’s BioAge Labs BIOA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.33K Sell
95
-70
-42% -$1.26K ﹤0.01% 1958
2026
Q1
$2.89K Buy
+165
New +$3.18K ﹤0.01% 1874

Other funds holding BIOA

MassMutual Private Wealth & Trust's BIOA Position: Q2 2026 in Review

MassMutual Private Wealth & Trust reduced its BioAge Labs (BIOA) stake by 42% in Q2 2026, selling an estimated $1.26K and leaving 95 shares worth $2.33K. The position accounts for ﹤0.01% of the portfolio, ranked #1958.

MassMutual Private Wealth & Trust first reported a position in BIOA in Q1 2026 and has held it in 2 quarters since. The position peaked at $2.89K in Q1 2026. 23 funds tracked by Wall St. Rank hold BIOA as of Q2 2026.

  • MassMutual Private Wealth & Trust held 95 shares of BioAge Labs worth $2.33K as of Q2 2026.
  • MassMutual Private Wealth & Trust sold 70 BioAge Labs shares in Q2 2026, an estimated $1.26K.
  • BioAge Labs made up ﹤0.01% of MassMutual Private Wealth & Trust's portfolio in Q2 2026, its #1958 holding.
  • MassMutual Private Wealth & Trust first reported a position in BioAge Labs in Q1 2026 and has held it in 2 quarters since.
  • MassMutual Private Wealth & Trust's BioAge Labs position peaked at $2.89K in Q1 2026.
  • 23 funds tracked by Wall St. Rank held BioAge Labs as of Q2 2026.

Based on MassMutual Private Wealth & Trust's 13F filing for Q2 2026, filed 2 Jul 2026.